Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort
Background: BICtegravir Single Tablet Regimen (BICSTaR) is an observational cohort study evaluating the effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve (TN) and treatment-experienced (TE) people with HIV. Objective: To present final pooled 24-...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis Group
2025-12-01
|
| coleção: | HIV Research & Clinical Practice |
| Assuntos: | |
| Acesso em linha: | http://dx.doi.org/10.1080/25787489.2025.2456890 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
